Literature DB >> 32948675

Dopaminergic Modulation of Human Intertemporal Choice: A Diffusion Model Analysis Using the D2-Receptor Antagonist Haloperidol.

Ben Wagner1, Mareike Clos2, Tobias Sommer2, Jan Peters1,2.   

Abstract

The neurotransmitter dopamine is implicated in diverse functions, including reward processing, reinforcement learning, and cognitive control. The tendency to discount future rewards over time has long been discussed in the context of potential dopaminergic modulation. Here we examined the effect of a single dose of the D2 receptor antagonist haloperidol (2 mg) on temporal discounting in healthy female and male human participants. Our approach extends previous pharmacological studies in two ways. First, we applied combined temporal discounting drift diffusion models to examine choice dynamics. Second, we examined dopaminergic modulation of reward magnitude effects on temporal discounting. Hierarchical Bayesian parameter estimation revealed that the data were best accounted for by a temporal discounting drift diffusion model with nonlinear trialwise drift rate scaling. This model showed good parameter recovery, and posterior predictive checks revealed that it accurately reproduced the relationship between decision conflict and response times in individual participants. We observed reduced temporal discounting and substantially faster nondecision times under haloperidol compared with placebo. Discounting was steeper for low versus high reward magnitudes, but this effect was largely unaffected by haloperidol. Results were corroborated by model-free analyses and modeling via more standard approaches. We previously reported elevated caudate activation under haloperidol in this sample of participants, supporting the idea that haloperidol elevated dopamine neurotransmission (e.g., by blocking inhibitory feedback via presynaptic D2 auto-receptors). The present results reveal that this is associated with an augmentation of both lower-level (nondecision time) and higher-level (temporal discounting) components of the decision process.SIGNIFICANCE STATEMENT Dopamine is implicated in reward processing, reinforcement learning, and cognitive control. Here we examined the effects of a single dose of the D2 receptor antagonist haloperidol on temporal discounting and choice dynamics during the decision process. We extend previous studies by applying computational modeling using the drift diffusion model, which revealed that haloperidol reduced the nondecision time and reduced impulsive choice compared with placebo. These findings are compatible with a haloperidol-induced increase in striatal dopamine (e.g., because of a presynaptic mechanism). Our data provide novel insights into the contributions of dopamine to value-based decision-making and highlight how comprehensive model-based analyses using sequential sampling models can inform the effects of pharmacological modulation on choice processes.
Copyright © 2020 the authors.

Entities:  

Keywords:  computational modeling; decision making; dopamine; haloperidol; intertemporal choice; pharmacology

Mesh:

Substances:

Year:  2020        PMID: 32948675      PMCID: PMC7548690          DOI: 10.1523/JNEUROSCI.0592-20.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  60 in total

Review 1.  From reinforcement learning models to psychiatric and neurological disorders.

Authors:  Tiago V Maia; Michael J Frank
Journal:  Nat Neurosci       Date:  2011-02       Impact factor: 24.884

Review 2.  A discounting framework for choice with delayed and probabilistic rewards.

Authors:  Leonard Green; Joel Myerson
Journal:  Psychol Bull       Date:  2004-09       Impact factor: 17.737

Review 3.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

4.  Steep discounting of delayed monetary and food rewards in obesity: a meta-analysis.

Authors:  M Amlung; T Petker; J Jackson; I Balodis; J MacKillop
Journal:  Psychol Med       Date:  2016-06-15       Impact factor: 7.723

5.  Dopamine Enhances Item Novelty Detection via Hippocampal and Associative Recall via Left Lateral Prefrontal Cortex Mechanisms.

Authors:  Mareike Clos; Nico Bunzeck; Tobias Sommer
Journal:  J Neurosci       Date:  2019-08-12       Impact factor: 6.167

6.  Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans.

Authors:  Mathias Pessiglione; Ben Seymour; Guillaume Flandin; Raymond J Dolan; Chris D Frith
Journal:  Nature       Date:  2006-08-23       Impact factor: 49.962

7.  Bupropion improves attention but does not affect impulsive behavior in healthy young adults.

Authors:  Ashley Acheson; Harriet de Wit
Journal:  Exp Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.157

Review 8.  Impulsive actions and choices in laboratory animals and humans: effects of high vs. low dopamine states produced by systemic treatments given to neurologically intact subjects.

Authors:  Valérie D'Amour-Horvat; Marco Leyton
Journal:  Front Behav Neurosci       Date:  2014-12-23       Impact factor: 3.558

9.  Baseline impulsivity may moderate L-DOPA effects on value-based decision-making.

Authors:  Johannes Petzold; Annika Kienast; Ying Lee; Shakoor Pooseh; Edythe D London; Thomas Goschke; Michael N Smolka
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

10.  More Is Meaningful: The Magnitude Effect in Intertemporal Choice Depends on Self-Control.

Authors:  Ian C Ballard; Bokyung Kim; Anthony Liatsis; Gökhan Aydogan; Jonathan D Cohen; Samuel M McClure
Journal:  Psychol Sci       Date:  2017-08-31
View more
  2 in total

1.  Motor response vigour and visual fixation patterns reflect subjective valuation during intertemporal choice.

Authors:  Elke Smith; Jan Peters
Journal:  PLoS Comput Biol       Date:  2022-06-10       Impact factor: 4.779

2.  Reliability assessment of temporal discounting measures in virtual reality environments.

Authors:  Luca R Bruder; Lisa Scharer; Jan Peters
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.